Familial hypercholesterolaemia
Gene: CYP27A1
Comment on list classification: Included on this panel as a differential diagnosis for FH, particularly with the presence of xanthomas.Created: 4 Dec 2024, 1:58 a.m. | Last Modified: 4 Dec 2024, 1:58 a.m.
Panel Version: 0.37
Well-established gene-disease association (see OMIM entry). Cerebrotendinous xanthomatosis is classified as a metabolic disorder by the NIH GARD (https://rarediseases.info.nih.gov/diseases/diseases-by-category/14/metabolic-disorders), and is an inborn error of bile acid metabolism.
Sources: NHS GMSCreated: 3 Feb 2021, 12:54 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Cerebrotendinous xanthomatosis MIM#213700; Disorders of bile acid biosynthesis
Publications
Variants in this GENE are reported as part of current diagnostic practice
Gene: cyp27a1 has been classified as Green List (High Evidence).
Phenotypes for gene: CYP27A1 were changed from to Cerebrotendinous xanthomatosis MONDO:0008948
Gene: cyp27a1 has been classified as Green List (High Evidence).
Mode of inheritance for gene: CYP27A1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: CYP27A1 was added gene: CYP27A1 was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: CYP27A1 was set to Unknown